Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 6, 2020
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
Wed, August 5, 2020
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $43 on, Aug 5th, 2020
Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $45 to $43 on, Aug 5th, 2020.
Matthew has made no other calls on AVNS in the last 4 months.
There are 2 other peers that have a rating on AVNS. Out of the 2 peers that are also analyzing AVNS, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kristen Stewart of "Barclays" Upgraded from Sell to Hold on, Monday, April 13th, 2020
This is the rating of the analyst that currently disagrees with Matthew
- David Lewis of "Morgan Stanley" Maintained at Sell with Increased Target to $31 on, Thursday, May 7th, 2020
